A feasibility study of the physiotherapy management of urinary incontinence in athletic women: trial protocol for the POsITIve study

Pilot and Feasibility Studies
K Gillian CampbellAvril Drummond

Abstract

Urinary incontinence (UI) affects up to 40% of adult women within the UK, and pelvic floor muscle training can be effective as a treatment. The prevalence of UI is higher in athletic women than in their sedentary counterparts, but there is little research into reasons for this or into treatment within this population.The aim of this study is to investigate the feasibility of conducting a future randomised controlled trial of physiotherapeutic management of UI in athletic women. This is a mixed methods study with three distinct but related phases.Phase 1: Semi-structured interviews with health care professionals in the community will explore current management practices of UI in women and particularly in female athletes in order to inform the control arm of a future study. It will also establish community health care professionals' understanding of pelvic health physiotherapy.Phase 2: Athletic and regularly exercising women recruited directly from gyms and sports clubs will undergo a course of physiotherapy to manage UI. This will establish study recruitment, eligibility, consent, attendance, attrition, and data completion rates. It will provide information regarding appropriate clinical venues and outcome measures to use for th...Continue Reading

Associated Clinical Trials

References

Jul 22, 1998·Journal of the American Geriatrics Society·J M MillerJ O DeLancey
Oct 8, 2003·International Urogynecology Journal and Pelvic Floor Dysfunction·M P FitzGerald, R Kotarinos
Jul 1, 2004·Neurourology and Urodynamics·Kerry AveryPaul Abrams
Aug 2, 2005·Obstetrics and Gynecology·Ingrid NygaardBarbara Sternfeld
Oct 28, 2005·Occupational Medicine·Nancy FultzBarbara Sternfeld
Feb 7, 2006·American Journal of Obstetrics and Gynecology·Kim N DanforthFrancine Grodstein
Feb 14, 2006·The Journal of Urology·Paul AbramsUNKNOWN ICIQ Advisory Board
Feb 21, 2009·Neurourology and Urodynamics·Margareta NilssonLalos Othon
Mar 14, 2009·Neurourology and Urodynamics·Huub van de VaartRalf Tunn
Feb 10, 2011·Neurourology and Urodynamics·Kari BøJorunn Sundgot-Borgen
May 17, 2011·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·Cristina JácomePedro Sá-Couto
May 4, 2012·International Urogynecology Journal·Thuane Da RozaTeresa Mascarenhas
Sep 21, 2013·BMC Medical Research Methodology·Nicola K GaleSabi Redwood
Aug 12, 2014·Best Practice & Research. Clinical Obstetrics & Gynaecology·Dee Hartmann, Julie Sarton
Nov 29, 2015·Qualitative Health Research·Kirsti MalterudAnn Dorrit Guassora
Feb 13, 2016·International Urogynecology Journal·Sally McKenzieKathy Briffa
Jan 28, 2017·BMC Health Services Research·Mandeep SekhonJill J Francis
Aug 10, 2017·Translational Andrology and Urology·Hau Choong AwHelen E O'Connell
Sep 28, 2017·International Journal of Sports Medicine·Jessica Oliveira AlvesThuane Da Roza
Oct 5, 2017·Revista da Associação Médica Brasileira·Marlene OliveiraPaula Clara Santos
Jun 24, 2018·International Urogynecology Journal·Keyla Mara Dos SantosSoraia Cristina Tonon da Luz
Oct 6, 2018·The Cochrane Database of Systematic Reviews·Chantale DumoulinE Jean C Hay-Smith
Feb 14, 2019·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·Birte J WolffColleen M Fitzgerald
Dec 11, 2019·Sports Medicine·Kari Bø, Ingrid Elisabeth Nygaard

❮ Previous
Next ❯

Clinical Trials Mentioned

NCT03986411

Software Mentioned

Living With
NVivo

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.